Integra LifeSciences Holdings Corporation (IART)

Market Cap	1.15B
Revenue (ttm)	1.62B
Net Income (ttm)	-500.63M
Shares Out	77.91M
EPS (ttm)	-6.54
PE Ratio	n/a
Forward PE	6.15
Dividend	n/a
Ex-Dividend Date	n/a

Volume	926,632
Open	14.83
Previous Close	14.83
Day's Range	14.75 - 15.69
52-Week Range	11.06 - 27.13
Beta	1.20
Analysts	Hold
Price Target	18.17 (+22.77%)
Earnings Date	Nov 3, 2025

About IART

Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamp...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 16, 1995
• Employees: 4,396
• Stock Exchange: NASDAQ
• Ticker Symbol: IART
• Website: https://www.integralife.com

Analyst Summary

According to 8 analysts, the average rating for IART stock is "Hold." The 12-month stock price target is $18.17, which is an increase of 22.77% from the latest price.

Price Target

$18.17

(22.77% upside)

Analyst Consensus: Hold